Tamarac, FL, Jan. 13, 2016 (GLOBE NEWSWIRE) -- Leading nutritional supplement manufacturer IQ Formulations and its CEO Jay Cohen were the focus of a detailed feature piece recently published in Business View Magazine. The eight-page-long article in the publication’s January issue highlights Cohen’s vision of elevating the standards of the supplement industry when creating IQ Formulations in 2010, and the incredible success story that has followed.
“Cohen’s firm has been on an astonishing trajectory of growth since its inception, going from less than $124,000 in 2010 revenue, to 2015 sales of $20 million, today – a growth rate of 5,428 percent over the last three years,” the article states. But as the piece also notes, the CEO was set on doing things his own way, seeking to bring top-quality formulations to an industry that had lost sight of its true purpose.
The response was strong. As Cohen says in the article: “People welcomed it with open arms, because it was such a different philosophy, such a different product line. It brought integrity back into the industry. Our philosophy was to become a vertically integrated company that would put the research, the development, the manufacturing, and the production all under one roof. It was like a breath of fresh air.”
Customers were even willing to pay a premium for the products due to their superiority. “We felt consumers were ready for that,” Cohen continued. “They found that when they drank [our product], they felt better…felt healthier…lost weight and had more energy. It transformed that segment of the marketplace within a year.”
While the company continues to experience overwhelming consumer demand on an ongoing basis, CEO Jay Cohen is sure to regulate the growth to ensure optimum product quality and consistency – part of IQ Formulations’ key commitment to the customers it serves. Built upon a strong belief that it is their duty to help educate people about what they put into their bodies, the company seeks to elevate standards, not just for its own products, but for the supplement industry overall. IQ Formulations’ high-tech facilities, rigorous product testing and elite supplements, as well as its commitment to philanthropy, clearly demonstrate this mission of leading by example.
To read the full article in Business View Magazine, visit: https://www.businessviewmagazine.com/digital-magazines/jan-2016/#62
About IQ Formulations
IQ Formulations is one of the most highly regarded and fastest growing health and nutritional supplement companies in the U.S. Founded by industry veteran and IQ Formulations CEO Jay Cohen, IQ Formulations is headquartered in Tamarac, Florida. The company has become an industry leader known for its uncompromising commitment to professional facilities, top-quality products with amazing results, and superior customer service. Learn more at iqformulations.com.
Pamela Armstrong [email protected] 954-379-2115 x403


First Western Ship Transits Strait of Hormuz Since Iran War Began
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Britain Courts Anthropic Amid US Defense Department Dispute
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 



